Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-16 Purchase |
2022-08-16 4:25 pm |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
5,000 | $0.8 | $4,000 | 5,335,433 (Direct) |
View |
| 2022-05-27 Purchase |
2022-05-31 10:16 am |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
5,000 | $0.976 | $4,880 | 5,330,433 (Direct) |
View |
| 2022-05-20 Purchase |
2022-05-23 4:57 pm |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
10,000 | $0.6 | $6,000 | 5,325,433 (Direct) |
View |
| 2022-05-19 Purchase |
2022-05-23 4:54 pm |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
3,948 | $0.644 | $2,543 | 48,091 (Direct) |
View |
| 2021-11-17 Purchase |
2021-11-19 08:13 am |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
23,589 | $1.9737 | $46,558 | 5,317,169 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-30 Option Award |
2023-07-05 9:18 pm |
N/A 2030-06-30 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
6,667 | $0 | 6,667 (Indirect) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:16 pm |
N/A 2030-06-30 |
Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director |
6,667 | $0 | 6,667 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:12 pm |
N/A 2033-06-30 |
Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director |
6,667 | $0 | 6,667 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:11 pm |
N/A 2030-06-30 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
6,667 | $0 | 6,667 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:00 pm |
N/A 2030-03-01 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
210,000 | $0 | 210,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:00 pm |
N/A 2023-03-01 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer |
90,000 | $0 | 138,091 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 5:08 pm |
N/A 2032-09-01 |
Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2029-06-24 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2029-06-24 |
Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2029-06-24 |
Inhibikase Therapeutics Inc. | IKT | O'Farrell Elizabeth G. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2029-06-24 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2022-03-07 Option Award |
2022-03-21 4:05 pm |
N/A 2029-03-07 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
62,500 | $0 | 106,643 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-21 4:05 pm |
N/A 2029-03-07 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
125,000 | $0 | 5,440,433 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-09 8:22 pm |
N/A 2029-03-07 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer |
62,500 | $0 | 106,643 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-09 8:21 pm |
N/A 2029-03-07 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
125,000 | $0 | 5,440,433 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:25 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
21,853 | $2.02 | 5,315,433 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:25 pm |
N/A 2025-03-01 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
21,853 | $0 | 5,315,433 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 07:46 am |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
21,853 | $2.02 | 5,293,580 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 07:46 am |
N/A 2023-06-01 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
21,853 | $0 | 5,293,580 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 7:12 pm |
2022-06-25 2028-06-25 |
Inhibikase Therapeutics Inc. | IKT | O'Farrell Elizabeth G. Director |
22,677 | $0 | 22,677 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 7:11 pm |
2022-06-25 2028-06-25 |
Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director |
22,677 | $0 | 22,677 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 7:10 pm |
2022-06-25 2028-06-25 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
22,677 | $0 | 22,677 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 7:09 pm |
2022-06-25 2028-06-25 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
22,677 | $0 | 22,677 (Indirect) |
View |
| 2021-05-14 Exercise |
2021-05-18 5:46 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
43,707 | $0.38 | 5,271,727 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 5:46 pm |
2011-06-01 2021-06-01 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
43,707 | $0 | 5,271,727 (Direct) |
View |
| 2021-05-14 Tax Withholding |
2021-05-18 5:46 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
16,918 | $4.59 | 5,271,727 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:53 pm |
2021-12-22 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
6,825 | $0 | 6,825 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:53 pm |
2021-12-22 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | O'Farrell Elizabeth G. Director |
6,825 | $0 | 6,825 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:53 pm |
2021-12-22 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director |
6,825 | $0 | 6,825 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:52 pm |
2021-12-22 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
6,825 | $0 | 6,825 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:52 pm |
N/A 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:52 pm |
N/A 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
100,000 | $0 | 144,143 (Direct) |
View |
| 2020-12-28 Conversion |
2020-12-29 9:52 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
44,143 | $10 | 144,143 (Indirect) |
View |
| 2020-12-28 Conversion |
2020-12-29 9:52 pm |
2020-12-28 2021-12-31 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
441,432 | $0 | 144,143 (Indirect) |
View |
Ownership |
2020-12-22 8:42 pm |
2020-08-25 2027-08-25 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
0 | $0 | 171,854 (Indirect) |
View |
Ownership |
2020-12-22 8:41 pm |
2011-06-15 2031-06-15 |
Inhibikase Therapeutics Inc. | IKT | Kalman Daniel 10% Owner |
0 | $0 | 1,748,312 (Direct) |
View |
Ownership |
2020-12-22 8:41 pm |
2019-07-29 2026-07-28 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
0 | $0 | 131,122 (Direct) |
View |
Ownership |
2020-12-22 8:40 pm |
2019-09-01 2026-08-31 |
Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director |
0 | $0 | 131,122 (Direct) |
View |
Ownership |
2020-12-22 8:40 pm |
2019-09-01 2026-08-31 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
0 | $0 | 131,122 (Indirect) |
View |
Ownership |
2020-12-22 8:39 pm |
2019-03-01 2026-03-01 |
Inhibikase Therapeutics Inc. | IKT | O'Farrell Elizabeth G. Director |
0 | $0 | 131,122 (Direct) |
View |